openPR Logo
Press release

Investigation announced for Long-Term Investors in shares of Mallinckrodt plc (NYSE: MNK)

08-26-2019 09:30 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of current long term investors in Mallinckrodt plc (NYSE: MNK) shares.

An investigation on behalf of current long term investors in Mallinckrodt plc (NYSE: MNK) shares.

An investigation was announced for current long-term investors in shares of Mallinckrodt plc (NYSE: MNK) concerning potential breaches of fiduciary duties by certain directors of Mallinckrodt plc.

Investors who are current long term investors in Mallinckrodt plc (NYSE: MNK) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NYSE: MNK stocks follows a lawsuit filed against Mallinckrodt plc over alleged securities laws violations. The investigation on behalf of current long term investors in NYSE: MNK stocks, concerns whether certain Mallinckrodt directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the Southern District of New York the plaintiff alleges that the Defendants made false and/or misleading statements and/or failed to disclose that Acthar posed significant safety concerns that rendered it a non-viable treatment for ALS, that accordingly, Mallinckrodt overstated the viability of Acthar as an ALS treatment, and that as a result, the Company’s public statements were materially false and misleading at all relevant times.

Those who purchased shares of Mallinckrodt plc (NYSE: MNK) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long-Term Investors in shares of Mallinckrodt plc (NYSE: MNK) here

News-ID: 1826262 • Views: 1074

More Releases from Shareholders Foundation

NS8 Inc. Former Employee Alert: Investigation over possible Violations of Securi …
An investigation was announced over potential securities laws violations by NS8 Inc. and certain of its directors and officers in connection with certain financial statements. Former employees of NS8 Inc. should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether certain statements by NS8 Inc. regarding its business, its prospects and its operations were materially false and misleading
Update in Lawsuit for Investors in shares of The RealReal, Inc. (NASDAQ: REAL)
A lawsuit is pending for investors in The RealReal, Inc. (NASDAQ: REAL) over alleged violations of Federal Securities Laws by The RealReal, Inc. in connection RealReal’s June 2019 initial public stock offering (the “IPO”). Investors who purchased shares of The RealReal, Inc. (NASDAQ: REAL) have certain options and for certain investors are short and strict deadlines running. Deadline: January 24, 2020. NASDAQ: REAL investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Deadline on Sept. 28th upcoming in Lawsuit for Investors in shares of FirstEnerg …
The Shareholders Foundation announced that a deadline is coming up on September 28, 2020 in the lawsuit filed for certain investors of FirstEnergy Corp. (NYSE: FE) over alleged securities laws violations by FirstEnergy Corp. Investors who purchased shares of FirstEnergy Corp. (NYSE: FE) have certain options and there are strict and short deadlines running. Deadline: September 28, 2020. NYSE: FE stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)
Investigation announced for Long-Term Investors in shares of Co-Diagnostics, Inc …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Co-Diagnostics, Inc.. Investors who are current long term investors in Co-Diagnostics, Inc. (NASDAQ: CODX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: CODX stocks follows a lawsuit filed against Co-Diagnostics, Inc over

All 5 Releases


More Releases for Mallinckrodt

Global Radiopharmaceuticals Market 2019 - Bracco Imaging, Bayer, Mallinckrodt, N …
This new report by Eon Market Research, titled “Global Radiopharmaceuticals Market 2019 Research Report, 2015 – 2025” offers a comprehensive analysis of Radiopharmaceuticals industry at a global as well as regional and country level. Key facts analyzed in this report include the Radiopharmaceuticals market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025. This report primarily focuses on the study of the competitive
Codeine Market Demand And Inventory Analysis: Francopia, Noramco, Weifa, Mallinc …
The Global Codeine Market Overview: The Global Codeine Market Research Report is depicted by the presence of various worldwide, provincial, and local vendors. The market is highly fragmented with each player is focusing on to gain a Codeine market share. Exceptional competition due to the presence of several international players, recurrent variations in government protocols and regulations, and rapid advancements in technology to drive innovation are the key factors that drive
Ioversol Market Size 2017-2022 Ultraject, Guerbet, Mallinckrodt Pharmaceuticals
Ioversol market research 2017 Global market study " Ioversol Market Size 2017-2022 " analyses the crucial factors of the Ioversol market based on present industry situations, market demands, business strategies adopted by Ioversol market players and their growth scenario. This report isolates the Ioversol market based on the key players, Type, Application and Regions. The Ioversol report provides the past, present and future Ioversol industry Size, trends and the forecast information
Global Codeine Phosphate Market 2017- Mallinckrodt, Francopia, Noramco, Macfaria …
Global Codeine Phosphate Market 2017, presents a professional and in-depth study on the current state of the Codeine Phosphate market globally, providing basic overview of Codeine Phosphate market including definitions, classifications, applications and industry chain structure. Historical data available in the report elaborates on the development of the Codeine Phosphate market on a global and regional level. The report compares this data with the current Codeine Phosphate state of the
Global Codeine Phosphate Market 2017- Noramco, Macfarian Smith, Francopia, Malli …
The main objective of the report titled Global Codeine Phosphate Market is to give a complete idea of the Codeine Phosphate market for the duration of 2017-2022. The Codeine Phosphate report focuses on market overview, market growth factors, market segmentation, regional analysis and competitive players involved in Codeine Phosphate market. Global Codeine Phosphate market report provides qualitative and quantitative knowledge about Codeine Phosphate industry. The Codeine Phosphate report also provides various
Global Oxycodone Hydrochloride Market-Siegfried, Temad, Purdue Pharma, Mallinckr …
Global Oxycodone Hydrochloride Market report 2017 is an in-depth research on the current situation of the Oxycodone Hydrochloride industry. The Scope of the Oxycodone Hydrochloride research report: The Global Oxycodone Hydrochloride Market primarily includes a basic overview of the Oxycodone Hydrochloride industry. It also includes Oxycodone Hydrochloride definitions, classifications and applications. It segments the market by applications, types, regions, competitive players and also analyzes Oxycodone Hydrochloride market size, business share and Oxycodone